India’s regulators are tightening oversight as obesity drug makers race to shape demand in the country’s emerging weight-loss ...
After years of windfall gains from cancer drug Lenalidomide in the US market, Dr. Reddy's Laboratories is entering a new ...
Dr Reddy's Laboratories is days away from launching a generic version of semaglutide in Canada, where it was the first to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results